Diane Haldane

Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data

Julie Beyrer, Janna Manjelievskaia, Machaon Bonafede et al. · Pharmacoepidemiology and Drug Safety · 2021 · 42 citations · Full text

Health Professions, Health Sciences, Clinical Classification Systems +16

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021

Lisa M. Hess, Peter M. Krein, Diane Haldane et al. · JTO Clinical and Research Reports · 2022 · 38 citations · Full text

Medicine, Oncology, Molecular Diagnostics +12

Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis

Elizabeth L. Eby, Ping Wang, Bradley Curtis et al. · Journal of Medical Economics · 2013 · 31 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

Healthcare Costs and Adherence Associated with Human Regular U-500 Versus High-Dose U-100 Insulin in Patients with Diabets

Elizabeth L. Eby, Anthony J. Zagar, Ping Wang et al. · Endocrine Practice · 2014 · 28 citations

Medicine, Endocrinology, Pharmacoeconomics +13

Treatment patterns and resource use among patients with comorbid diabetes mellitus and major depressive disorder

T. Kim Le, Brad Curtis, Kristin Kahle‐Wrobleski et al. · Journal of Medical Economics · 2011 · 23 citations

Education, Psychiatry, Behavioral Health +15